India MCA Corporate Compliance Enforcement — May 16, 2026

Q4 FY26 consolidated revenue surged 162% YoY to ₹313.73 Cr with PAT up 118% YoY to ₹43.79 Cr, outpacing full-year EBITDA growth of only 6%

Promoter exercised 5,00,000 warrants for ₹17.30 Cr in Q4 FY26 subscription totaling ₹35.68 Cr, demonstrating high insider conviction

ICRA Long Term rating upgraded to A+ (Positive) and Short Term to A1+ (Positive) alongside NABL accreditation for third consecutive year

Total capacity expanded to 200,000 MTPA including 80,000 MTPA Brookshire USA facility post-CrudeChem acquisition at 53.33% stake

YoY volume growth of 131% in Q4 driven by optimal CrudeChem utilization and new Midland Permian Basin plant

Board confirmed non-compliance beyond control due to Ministry oversight, with waiver application submitted mitigating fine impact of ₹4.6L

Great Place to Work certification renewed for fourth year supporting operational stability post-expansion

Medium risk regulatory action flagged with 7/10 materiality indicating potential compliance overhang versus sector peers

BSE fine of ₹4,60,000 + GST for Reg 17(1) board composition non-compliance in Q3 FY26 with waiver pending

Full-year FY26 EBITDA grew only 6% to ₹134.75 Cr versus 45% revenue growth, signaling margin compression pressure

Medium risk rating with 7/10 materiality in MCA enforcement stream highlights elevated regulatory exposure

53.33% CrudeChem stake integration carries execution risk despite capacity ramp to 80,000 MTPA

Director appointments controlled by Ministry of Chemicals creating recurring compliance vulnerability

Warrant conversion added promoter stake but increased total shares potentially pressuring EPS

200,000 MTPA total capacity across five plants with US Brookshire facility positions for Permian Basin volume surge post-Q4 FY26

ICRA A+ (Positive) upgrade enables lower borrowing costs for further M&A or expansions in chemicals sector

Promoter warrant exercise of ₹17.30 Cr signals confidence ahead of potential FY27 guidance acceleration

Pending BSE fine waiver for ₹4.6L non-compliance could remove overhang if approved post-15.05.2026 board review

131% YoY volume growth and 80,000 MTPA US capacity provide relative outperformance versus peers in regulatory-heavy filings

Optimal efficiency levels at acquired assets support margin recovery trajectory in FY27

3/5 filings involve MCA/SEBI compliance actions with average materiality 6.2/10, concentrated in chemicals and jewelry sectors during May 2026 window

Fineotex achieved 80,000 MTPA US footprint via acquisition while HOCL remains domestically constrained by government control, highlighting cross-border divergence

Fineotex posted 162% Q4 revenue growth but only 105% EBITDA growth indicating 200+ bps margin dilution from integration costs across chemical majors

Warrant conversions totaling ₹35.68 Cr in Fineotex versus minimal insider activity in regulatory-flagged peers signals differentiated management confidence

BSE response to ₹4.6L fine waiver application expected post-15.05.2026 board meeting review

Monitor earnings call for capacity utilization updates on 200,000 MTPA and CrudeChem contribution

Track ICRA outlook changes following Q4 expansion and warrant conversion completion

Follow-up MCA enforcement details due given 7/10 materiality flag in May 2026 filings

Watch Q1 FY27 production metrics for sustainment of 131% YoY volume growth post-US facility ramp